As of Jun 26
| -0.0124 / -1.80%|
The 1 analysts offering 12-month price forecasts for Xtant Medical Holdings Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +122.06% increase from the last price of 0.68.
The current consensus among 2 polled investment analysts is to Buy stock in Xtant Medical Holdings Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.